Britain’s Quiet Health Revolution: When Delaying Disease Becomes a Postcode Lottery
The NHS approves teplizumab, the first drug to delay type 1 diabetes—but access depends on where you live. A medical breakthrough collides with Britain’s systemic inequalities.